| Trial ID: | L3241 |
| Source ID: | NCT04117763
|
| Associated Drug: |
Empagliflozin 25 Mg
|
| Title: |
Effect of Empagliflozin on Ventricular Repolarization.
|
| Acronym: |
EMPATHYHEART
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Coronary Heart Disease|Arrythmia, Cardiac
|
| Interventions: |
DRUG: Empagliflozin 25 MG
|
| Outcome Measures: |
Primary: Arrhythmogenic burden, Analysis of the T-wave heterogeneity index, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Sao Paulo
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2019-10-04
|
| Completion Date: |
2024-03-31
|
| Results First Posted: |
|
| Last Update Posted: |
2024-05-08
|
| Locations: |
InCor, São Paulo, SP, 05403-000, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT04117763
|
